Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.

Mbuagbaw L, Guglielmetti L, Hewison C, Bakare N, Bastard M, Caumes E, Fréchet-Jachym M, Robert J, Veziris N, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Schünemann HJ, Lienhardt C.

Emerg Infect Dis. 2019 May;25(5):936-943. doi: 10.3201/eid2505.181823.

2.

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.

Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, Van Baelen B, van Heeswijk RP, Dannemann B; TMC207-C209 Study Group.

Eur Respir J. 2016 Feb;47(2):564-74. doi: 10.1183/13993003.00724-2015. Epub 2015 Dec 2.

3.

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

Diacon AH, Pym A, Grobusch MP, de los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, De Paepe E, van Heeswijk RP, Dannemann B; TMC207-C208 Study Group.

N Engl J Med. 2014 Aug 21;371(8):723-32. doi: 10.1056/NEJMoa1313865.

4.

Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.

Tőke ER, Lőrincz O, Csiszovszki Z, Somogyi E, Felföldi G, Molnár L, Szipőcs R, Kolonics A, Malissen B, Lori F, Trocio J, Bakare N, Horkay F, Romani N, Tripp CH, Stoitzner P, Lisziewicz J.

Gene Ther. 2014 Jun;21(6):566-74. doi: 10.1038/gt.2014.29. Epub 2014 Apr 3.

PMID:
24694539
5.

Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.

Lisziewicz J, Bakare N, Calarota SA, Bánhegyi D, Szlávik J, Ujhelyi E, Tőke ER, Molnár L, Lisziewicz Z, Autran B, Lori F.

PLoS One. 2012;7(5):e35416. doi: 10.1371/journal.pone.0035416. Epub 2012 May 9.

6.

Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities.

Bakare N, Edwards IR, Stergachis A, Pal S, Holmes CB, Lindquist M, Duncombe C, Dodoo A, Novendstern J, Nwokike J, Kuchenbecker R, Aberg JA, Miller V, Strobos J.

PLoS Med. 2011 Jul;8(7):e1001054. doi: 10.1371/journal.pmed.1001054. Epub 2011 Jul 5. No abstract available.

7.

Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS).

Bakare N, Menschik D, Tiernan R, Hua W, Martin D.

Vaccine. 2010 Sep 14;28(40):6609-12. doi: 10.1016/j.vaccine.2010.07.039. Epub 2010 Jul 30.

PMID:
20674876
8.

HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.

Cristillo AD, Lisziewicz J, He L, Lori F, Galmin L, Trocio JN, Unangst T, Whitman L, Hudacik L, Bakare N, Whitney S, Restrepo S, Suschak J, Ferrari MG, Chung HK, Kalyanaraman VS, Markham P, Pal R.

Virology. 2007 Sep 15;366(1):197-211. Epub 2007 May 11.

9.

Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms.

Lori F, Foli A, Groff A, Lova L, Whitman L, Bakare N, Pollard RB, Lisziewicz J.

AIDS. 2005 Jul 22;19(11):1173-81.

PMID:
15990570
10.

Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.

Lori F, Pollard RB, Whitman L, Bakare N, Blick G, Shalit P, Foli A, Peterson D, Tennenberg A, Schrader S, Rashbaum B, Farthing C, Herman D, Norris D, Greiger P, Frank I, Groff A, Lova L, Asmuth D, Lisziewicz J.

AIDS Res Hum Retroviruses. 2005 Apr;21(4):263-72.

PMID:
15943568
11.

DermaVir, a novel HIV immunisation technology.

Lori F, Trocio J, Bakare N, Kelly LM, Lisziewicz J.

Vaccine. 2005 Mar 18;23(17-18):2030-4.

PMID:
15755566
12.

DermaVir: a novel topical vaccine for HIV/AIDS.

Lisziewicz J, Trocio J, Whitman L, Varga G, Xu J, Bakare N, Erbacher P, Fox C, Woodward R, Markham P, Arya S, Behr JP, Lori F.

J Invest Dermatol. 2005 Jan;124(1):160-9.

13.

Control of viral rebound through therapeutic immunization with DermaVir.

Lisziewicz J, Trocio J, Xu J, Whitman L, Ryder A, Bakare N, Lewis MG, Wagner W, Pistorio A, Arya S, Lori F.

AIDS. 2005 Jan 3;19(1):35-43.

PMID:
15627031
14.

Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis.

Bakare N, Rickerts V, Bargon J, Just-Nübling G.

Mycoses. 2003 Feb;46(1-2):19-23.

PMID:
12588478
15.

Therapeutic vaccination for future management of HIV/AIDS.

Lisziewicz J, Bakare N, Lori F.

Vaccine. 2003 Jan 30;21(7-8):620-3. Review.

PMID:
12531329
16.

Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.

Ige OM, Bakare NA, Onadeko BO.

Afr J Med Med Sci. 2000 Mar;29(1):51-3.

PMID:
11379469

Supplemental Content

Loading ...
Support Center